SCHEMBL13639172

SCHEMBL13639172

Cc1cc(Cl)cc(C)c1OC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 4/20 0.48
GAA P10253 1/20 0.41
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
ATM Q13315 1/20 0.37
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
CXCR5 P32302 1/20 0.33
PLAU P00749 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
USP2 O75604 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10358893 0.82 SCN4A (0.46) SCN4ATSHRHTR2AHTR2CHTR2B
SCHEMBL12517837 0.80 FFAR4 (0.41) GAAALDH1A1PLAUMAPT
SCHEMBL19940003 0.78 PLAU (0.42) GAAALDH1A1LMNAKMT2APLAU
SCHEMBL19088279 0.78 GAA (0.42) SCN4AGAAALDH1A1TSHRLMNA
SCHEMBL18726947 0.76 CXCR5 (0.32) MEN1KMT2ACXCR5PLAU
SCHEMBL12180582 0.76 LMNA (0.37) LMNAMEN1KMT2AGABRA1PLAU
SCHEMBL2544650 0.76 LMNA (0.36) ALDH1A1LMNAMEN1KMT2AGABRA1
SCHEMBL12401803 0.74 POLB (0.43) TSHRGABRA1PLAU
SCHEMBL20624746 0.74 GAA (0.40) SCN4AGAAALDH1A1TSHRHTR2A
SCHEMBL24779632 0.73 TAS1R3 (0.37) GAAALDH1A1TSHRPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481976-B1 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2012-11-07 EP disclosed
US-7226950-B2 Sodium channel modulators THERAVANCE, INC. (US) 2007-06-05 US disclosed